Telomere Maintenance Mechanisms Define Clinical Outcome in High-Risk Neuroblastoma-Reference-Cited by-同舟云学术

Telomere Maintenance Mechanisms Define Clinical Outcome in High-Risk Neuroblastoma

Published:2020-04-14 Issue:12 Volume:80 Page:2663-2675
ISSN:0008-5472
Container-title:Cancer Research
language:en
Short-container-title:Cancer Res

Author:

Koneru Balakrishna^ORCID,Lopez Gonzalo^ORCID,Farooqi Ahsan,Conkrite Karina L.^ORCID,Nguyen Thinh H.,Macha Shawn J.,Modi Apexa^ORCID,Rokita Jo Lynne^ORCID,Urias Eduardo,Hindle Ashly,Davidson Heather,Mccoy Kristyn,Nance Jonas,Yazdani Vanda,Irwin Meredith S.,Yang Shengping,Wheeler David A.^ORCID,Maris John M.^ORCID,Diskin Sharon J.,Reynolds C. Patrick^ORCID

Funder

Cancer Prevention & Research Institute of Texas

NCI

NIH

COGAlex's Lemonade Stand FoundationAlex's Lemonade Stand Foundation

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence of alternative lengthening of telomeres in pediatric sarcomas determined by the telomeric DNA C-circle assay;Frontiers in Oncology;2024-08-19

2. Loss of Chromosome Y in Neuroblastoma Is Associated With High‐Risk Disease, 11q‐Deletion, and Telomere Maintenance;Genes, Chromosomes and Cancer;2024-07

3. Overexpression of H2AFX gene in neuroblastoma is associated with worse prognosis;Pediatric Blood & Cancer;2024-06-27

4. The TERT Promoter is Polycomb-Repressed in Neuroblastoma Cells with Long Telomeres;Cancer Research Communications;2024-06-20

5. Regulatory roles of insulin growth factor binding protein family in neuroblastoma cell proliferation and differentiation: Potential prognostic biomarkers and therapeutic targets for neuroblastoma;Pediatric Discovery;2024-06-08